Fundraising Fox

Nervonik

21 employees on LinkedIn · 6 known investors

Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation. The systems focus on connectivity, wearability, lead stability, and durability for medical device applications.

HardwareHealthtechMedical Devices

Investors · 6

Foothill VenturesLos Altos · $100K – $10M
Lumira VenturesToronto · $1M – $10M
ShangBay Capital LLCPalo Alto
US Venture PartnersMenlo Park · $500K – $10M
Amzak HealthreportedNew York

Also in the syndicate · 1

Elevage Medical Technologies

Funding

SEC filings, press & company announcements

$65.5M disclosed across 2 rounds · 2025–2026

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 3

by search overlap
Neuraptive11 shared keywordsNeuraptive develops therapeutics and medical products for peripheral nerve repair, including NTX-001, a surgical treatment kit for peripheral nerves following trauma or nerve reconstruction procedures. The company serves physicians and patients affected by peripheral nerve injuries in the U.S. market.
NeuroBionics11 shared keywordsNeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications. The company translates bioelectronic devices from preclinical research toward first-in-human studies and commercialization.
Rf Surgical10 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.

Companies competing with Nervonik for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Nervonik closes $52.5m Series B funding to advance PNS systemfinance.yahoo.com · Apr 2026Nervonik Raises $52.5M to Advance Smart Neuromodulation Implants | citybizcitybiz.co · Apr 2026Nervonik Raises $52.5M in Series B Fundingfinsmes.com · Apr 2026Nervonik Announces $52.5 Million Series B Financing to Advance Peripheral Nerve Stimulation Therapyprnewswire.com · Apr 2026Nervonik raises $13M Series A to support next-gen nerve stim techmassdevice.com · Mar 2025Nervonik Raises $13 Million in Series A Financing to Advance Next-Generation Peripheral Nerve Stimulation for Chronic Pain Reliefprnewswire.com · Mar 2025

Frequently asked questions

What does Nervonik do?
Nervonik develops peripheral nerve stimulation (PNS) systems designed for high-motion, dynamic activity, using a patented technology that adds biosensing and objective feedback to neuromodulation. The systems focus on connectivity, wearability, lead stability, and durability for medical device applications.
Who are Nervonik's investors?
Nervonik's investors include Foothill Ventures, Lumira Ventures, ShangBay Capital LLC, US Venture Partners, Amzak Health.
How much funding has Nervonik raised?
Nervonik has disclosed $65.5M raised across 2 rounds.